David Platt
Chief Executive Officer at BIOXYTRAN, INC.
Net worth: 9 M $ as of 29/04/2024
Active connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Dale Conaway | M | 69 |
Oxygen Therapy, Inc.
 Oxygen Therapy, Inc. Pharmaceuticals: MajorHealth Technology Oxygen Therapy, Inc. is an early stage pharmaceutical company, which engages in the development, manufacture, and commercialization of an innovative platform of oxygen therapeutic treatments for hypoxic conditions and necrosis prevention. Its product pipeline includes OTI-629, an anti-necrosis drug; and OTI-1011, a resuscitative agent for wound healing applications. The company was founded by David Platt on May 20, 2016 and is headquartered Newton, MA. | 22 years |
| Alan Hoberman | M | 71 |
Oxygen Therapy, Inc.
Oxygen Therapy, Inc. Pharmaceuticals: MajorHealth Technology Oxygen Therapy, Inc. is an early stage pharmaceutical company, which engages in the development, manufacture, and commercialization of an innovative platform of oxygen therapeutic treatments for hypoxic conditions and necrosis prevention. Its product pipeline includes OTI-629, an anti-necrosis drug; and OTI-1011, a resuscitative agent for wound healing applications. The company was founded by David Platt on May 20, 2016 and is headquartered Newton, MA. | 10 years |
| Ola Soderquist | M | 63 |
Oxygen Therapy, Inc.
Oxygen Therapy, Inc. Pharmaceuticals: MajorHealth Technology Oxygen Therapy, Inc. is an early stage pharmaceutical company, which engages in the development, manufacture, and commercialization of an innovative platform of oxygen therapeutic treatments for hypoxic conditions and necrosis prevention. Its product pipeline includes OTI-629, an anti-necrosis drug; and OTI-1011, a resuscitative agent for wound healing applications. The company was founded by David Platt on May 20, 2016 and is headquartered Newton, MA. | 2 years |
| Daniel Teper | M | 64 |
Oxygen Therapy, Inc.
Oxygen Therapy, Inc. Pharmaceuticals: MajorHealth Technology Oxygen Therapy, Inc. is an early stage pharmaceutical company, which engages in the development, manufacture, and commercialization of an innovative platform of oxygen therapeutic treatments for hypoxic conditions and necrosis prevention. Its product pipeline includes OTI-629, an anti-necrosis drug; and OTI-1011, a resuscitative agent for wound healing applications. The company was founded by David Platt on May 20, 2016 and is headquartered Newton, MA. | 6 years |
| Gilbert Amelio | M | 81 | 15 years | |
| Michael Sheikh | M | 54 | 4 years | |
| Benjamin Rivnay | M | - |
Oxygen Therapy, Inc.
Oxygen Therapy, Inc. Pharmaceuticals: MajorHealth Technology Oxygen Therapy, Inc. is an early stage pharmaceutical company, which engages in the development, manufacture, and commercialization of an innovative platform of oxygen therapeutic treatments for hypoxic conditions and necrosis prevention. Its product pipeline includes OTI-629, an anti-necrosis drug; and OTI-1011, a resuscitative agent for wound healing applications. The company was founded by David Platt on May 20, 2016 and is headquartered Newton, MA. | - |
| Anders Utter | M | 57 | 6 years | |
| Bruce R. Maxim | M | 70 |
University of Michigan
| 33 years |
| Alec Gallimore | M | 60 |
University of Michigan
| 32 years |
| Leslie Ajayi | M | - | - |
Connections Chart
Multi-company connection
Former connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Anthony Don Squeglia | M | 81 | 9 years | |
| Henry Jemil Esber | M | 86 |
Oxygen Therapy, Inc.
Oxygen Therapy, Inc. Pharmaceuticals: MajorHealth Technology Oxygen Therapy, Inc. is an early stage pharmaceutical company, which engages in the development, manufacture, and commercialization of an innovative platform of oxygen therapeutic treatments for hypoxic conditions and necrosis prevention. Its product pipeline includes OTI-629, an anti-necrosis drug; and OTI-1011, a resuscitative agent for wound healing applications. The company was founded by David Platt on May 20, 2016 and is headquartered Newton, MA. | 9 years |
| Kenneth A. Tassey | M | 62 | 5 years | |
| Peter Traber | M | 69 | 9 years | |
| Sydney Colin Neill | M | 77 | 11 years | |
| Carl Laurence Lueders | M | 74 | 7 years | |
| Usama Mohammad Fayyad | M | 60 |
University of Michigan
| 11 years |
| Chi-Heng Cheng | M | 47 | 8 years | |
| Maureen E. Foley | F | 83 | - | |
| Thomas A. McGauley | M | 51 | 4 years | |
| Randy Winograd | M | - |
University of Michigan
| 7 years |
| Rod D. Martin | M | 54 | - | |
| Shmoulik Barashi | M | 61 |
The Hebrew University of Jerusalem
| 7 years |
| Dafna Ravid Barzily | F | 60 |
The Hebrew University of Jerusalem
| 7 years |
| Daniel Beltzman | M | 49 |
University of Michigan
| 5 years |
| Mark Alhermizi | M | - |
University of Michigan
| 7 years |
| Hana Chen-Walden | M | 77 | - | |
| Isaac Benbenisti | M | 60 |
The Hebrew University of Jerusalem
| 6 years |
| Gideon Ben-Zvi | M | 63 |
The Hebrew University of Jerusalem
| 6 years |
| Ram Belinkov | M | 68 |
The Hebrew University of Jerusalem
| 8 years |
| Yoram Cohen | M | 58 |
The Hebrew University of Jerusalem
| 6 years |
| Yuval Kwintner | M | 61 |
Oxygen Therapy, Inc.
Oxygen Therapy, Inc. Pharmaceuticals: MajorHealth Technology Oxygen Therapy, Inc. is an early stage pharmaceutical company, which engages in the development, manufacture, and commercialization of an innovative platform of oxygen therapeutic treatments for hypoxic conditions and necrosis prevention. Its product pipeline includes OTI-629, an anti-necrosis drug; and OTI-1011, a resuscitative agent for wound healing applications. The company was founded by David Platt on May 20, 2016 and is headquartered Newton, MA. | - |
| Tanju Carnation | M | - |
University of Michigan
| 7 years |
| Eugene Kandel | M | - |
The Hebrew University of Jerusalem
| 10 years |
| Paul Brown | M | - |
University of Michigan
| 16 years |
| Bari Bar Zion | M | 59 |
The Hebrew University of Jerusalem
| 8 years |
| Yousef Salem Mohammad Najajreh | M | - |
The Hebrew University of Jerusalem
| 6 years |
| David Gordon | M | - |
The Hebrew University of Jerusalem
| 7 years |
| Dan Weintraub | M | 60 |
The Hebrew University of Jerusalem
| 6 years |
| Ran Cohen | M | 56 |
The Hebrew University of Jerusalem
| 6 years |
| Alona Weiss | M | - |
The Hebrew University of Jerusalem
| 11 years |
| Haim Elen Halfon | M | 59 |
The Hebrew University of Jerusalem
| 6 years |
| Theodore Daniel Zucconi | M | 77 | 11 years | |
| Jason B. Koenig | M | - |
University of Michigan
| 7 years |
| Jerald K. Rome | M | 88 | - | |
| Steven Prelack | M | 66 | 14 years | |
| Brian Stephen Matuszak | M | - |
University of Michigan
| 6 years |
| Marc Weiser | M | - |
University of Michigan
| 9 years |
| Charles Park | M | 57 |
University of Michigan
| 7 years |
| Jonathan Ilan Ofir | M | - |
The Hebrew University of Jerusalem
| 5 years |
| Moshe de Leon | M | - |
The Hebrew University of Jerusalem
| 6 years |
| David E. Wells | M | - |
University of Michigan
| 3 years |
| Morton Lorge | M | - |
University of Michigan
| 3 years |
| Deborah Mielewski | M | - |
University of Michigan
| 1 years |
| Marc Minikes | M | - |
University of Michigan
| 4 years |
| John Hale | M | - |
University of Michigan
| 7 years |
| Thomas Flaten | M | - |
University of Michigan
| 4 years |
| John Bishop | M | 50 |
University of Michigan
| 5 years |
| Eric Swayze | M | - |
University of Michigan
| 3 years |
| Stephen M. Schiestel | M | - |
University of Michigan
| 4 years |
| Joe Frohna | M | - |
University of Michigan
| 2 years |
| Brian Dowd | M | - |
University of Michigan
| 4 years |
| Erik Chalut | M | - |
University of Michigan
| 4 years |
| Michelle Lee | F | - |
University of Michigan
| 3 years |
| Erik Garr | M | - |
University of Michigan
| 4 years |
| Jonathan Berlent | M | 55 |
University of Michigan
| 4 years |
| Holly Ruxin | F | 54 |
University of Michigan
| 4 years |
| Robert Borthwick | M | - |
University of Michigan
| 3 years |
| Adam Alpert | M | - |
University of Michigan
| 4 years |
| Andrei Dorenbaum | M | - |
University of Michigan
| 4 years |
| Deron Goodwin | M | 58 |
University of Michigan
| 2 years |
| Richard Brandon | M | - |
University of Michigan
| 1 years |
| Garen Sarafian | M | - |
University of Michigan
| 3 years |
| Matthew Bower | M | - |
University of Michigan
| 3 years |
| Bill Cilluffo | M | - |
University of Michigan
| 3 years |
| Snehal Amin | M | - |
University of Michigan
| 3 years |
| Craig A. Greenberg | M | 50 |
University of Michigan
| 4 years |
| Jeffrey Gordon | M | - |
University of Michigan
| 4 years |
| Brian H. Sedrish | M | - |
University of Michigan
| 4 years |
| Sohab Rashid | M | - |
University of Michigan
| 2 years |
| Randy A. Bridgeman | M | - |
University of Michigan
| 3 years |
| Lawrence Sage | M | - |
University of Michigan
| 4 years |
| Ed O'Dowd | M | - |
University of Michigan
| 2 years |
| Dana L. Schmitt | F | - |
University of Michigan
| 4 years |
| Daryl R. Kipke | M | - |
University of Michigan
| 3 years |
| Matt HoganBruen | M | - |
University of Michigan
| 4 years |
| Marc Ferrentino | M | 49 |
University of Michigan
| 5 years |
| Ian Burnstein | M | 54 |
University of Michigan
| 4 years |
| Warren Henry Mondschein | M | - |
University of Michigan
| 3 years |
| Lois F. Marler | F | - |
University of Michigan
| 2 years |
| Andrea Lawrence | F | - |
University of Michigan
| 4 years |
| Kok Eng Ang | M | 57 |
University of Michigan
| 4 years |
| Brian W. Spolarich | M | - |
University of Michigan
| 4 years |
| Phillip Ahn | M | 54 |
University of Michigan
| 4 years |
| Samir Kaul | M | 50 |
University of Michigan
| 4 years |
| Dong-Yeon Kim | M | - |
University of Michigan
| 1 years |
| Jessica Kleiman | F | - |
University of Michigan
| 4 years |
| Adam J. Gacek | M | - |
University of Michigan
| 4 years |
| Burak Gokmen | M | - |
University of Michigan
| 1 years |
Statistics
| Country | Connections | % of total |
|---|---|---|
| United States | 84 | 84.00% |
| Israel | 16 | 16.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- David Platt
- Personal Network
